Stratos Wealth Partners, Ltd. Bluebird Bio, Inc. Transaction History

Stratos Wealth Partners, Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 29, 2020	SELL	$34.44 - $43.75 $157,080 - $199,543	-4,561 Closed	0 $0
Q2 2020 Jul 28, 2020	BUY	$27.12 - $45.97 $123,694 - $209,669	4,561 New	4,561 $278,000
Q4 2018 Feb 08, 2019	SELL	$59.1 - $93.26 $42,847 - $67,613	-725 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$88.86 - $117.49 $64,423 - $85,180	725 New	725 $106,000
Q2 2018 Aug 13, 2018	SELL	$99.64 - $127.59 $74,730 - $95,692	-750 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$105.8 - $150.94 $12,801 - $18,263	121 Added 19.24%	750 $128,000
Q4 2017 Feb 09, 2018	BUY	$81.25 - $130.7 $51,106 - $82,210	629	629 $112,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.